BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3502264)

  • 1. [Augmentation of killer activity in regional lymph nodes in gastric cancer by intratumoral injection of immunopotentiators].
    Akura Y
    Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2265-72. PubMed ID: 3502264
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study on enhancement of antitumor immunity in cervical cancer--with reference to administration of immunopotentiators].
    Wakida K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):432-8. PubMed ID: 3559328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Augmentation of cytotoxicity of regional lymph node lymphocytes of the stomach by in vitro culture in IL2 contained medium].
    Akura Y; Tanaka N; Gotoh K; Kamitani S; Gangi J; Ono M; Yoshihara H; Ohida J; Orita K
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2411-20. PubMed ID: 3494799
    [No Abstract]   [Full Text] [Related]  

  • 4. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
    Kobayashi G
    Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):68-76. PubMed ID: 2314383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation in cytotoxicity of lymphnode lymphocytes by OK-432.
    Tanaka N; Gotoh K; Kobayashi G; Gouchi A; Orita K
    Int J Immunopharmacol; 1994 Feb; 16(2):131-5. PubMed ID: 8181902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Augmentation of cytotoxicity of tumor infiltrating lymphocytes by interleukin-2 in gastric cancer patients].
    Gotoh K
    Nihon Geka Gakkai Zasshi; 1985 Dec; 86(12):1600-7. PubMed ID: 3878935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunochemotherapy for cancer patients of the stomach--cancer therapy keeping with good host-immunocompetency].
    Saji S; Kunieda K; Sugiyama Y
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():420-6. PubMed ID: 11424418
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of streptococcal lyzate OK-432 on peripheral blood mononuclear cells in gastric cancer patients.
    Nakayama F; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N
    J Med; 1998; 29(3-4):199-215. PubMed ID: 9865458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated killer cell activity in lymph nodes.
    Akiyoshi T; Koba F; Tsuji H
    J Clin Lab Immunol; 1987 Feb; 22(2):91-5. PubMed ID: 3496459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
    Sakai Y; Maeda M; Koyama W; Totsuka S; Sakamoto S; Kanayama M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1978-80. PubMed ID: 3382244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adjuvant chemotherapy for gastric cancer].
    Yoshida K; Toge T
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():449-55. PubMed ID: 11424424
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of BRMs in gastric cancer patients].
    Ochiai T; Isono K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1609-14. PubMed ID: 2968070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell activity in the perigastric lymph nodes from patients with gastric carcinoma or benign lesions.
    Koba F; Akiyoshi T; Tsuji H
    J Clin Lab Immunol; 1987 Aug; 23(4):191-5. PubMed ID: 2959787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of immunological response of regional lymph node lymphocytes from patients with gastric cancer after endoscopic local injection of biological response modifier (BRM)].
    Obi Y
    Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):293-302. PubMed ID: 2051981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the cell-mediated immunity in regional lymph nodes from patients with gastric cancer].
    Koba F
    Fukuoka Igaku Zasshi; 1985 Apr; 76(4):104-16. PubMed ID: 3875541
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of endoscopic local injection of OK-432 on regional lymph nodes in gastric cancer patients].
    Ogawara T; Sakai K; Sekikawa T; Kouno K; Matsumoto Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1601-4. PubMed ID: 1530316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Distribution of lymphocyte subpopulation and natural killer activity in gastric cancer tissue, normal stomach and various tissues of gastric cancer patients].
    Moritani Y
    Nihon Geka Gakkai Zasshi; 1984 Feb; 85(2):132-42. PubMed ID: 6611484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of intratumoral injection of the mixture of OK-432 and fibrinogen (OK/fbg) on gastric cancer].
    Takeda T; Wakasugi T; Katsumoto Y; Sakita I; Nagaoka H; Morimoto H; Tsujinaka T; Monden T; Shiozaki H; Shimano T
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1458-60. PubMed ID: 1530293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
    van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
    Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the oral or intratumoral administration of OK432 on the immuno-reactivities of regional lymph nodes in gastric cancer patients.
    Yanagawa E; Toge T; Yamaguchi Y; Kuninobu H; Kuroi K; Kegoya Y; Baba N; Takayama T; Sato Y
    Jpn J Surg; 1991 May; 21(3):297-303. PubMed ID: 1857033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.